SANUWAVE Health Inc. (SNWV)
SNWV trades on Nasdaq in Health Care, Medical/Dental Instruments. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:Revenues), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1417663/000162828026021443/0001628280-26-021443-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.
Profile
| Field | Value |
|---|---|
| Ticker | SNWV on Nasdaq |
| Sector | Health Care |
| Industry | Medical/Dental Instruments |
| Country | United States |
| IPO year | Not reported by the screener |
| SEC CIK | 0001417663 |
| SEC industry code | Surgical & Medical Instruments & Apparatus |
| Incorporated in | NV |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $44.1M |
| Net income | $11.8M |
| Operating income | $4.9M |
| Net margin | 26.8% |
| Operating margin | 11.2% |
| Revenue growth | +35.0% |
| Cash | $12.0M |
| Total assets | $37.3M |
| P/E (computed) | 1.3× |
| P/S (computed) | 0.4× |
Warning signs
| Sign | Finding | Source |
|---|---|---|
| Going concern | No going-concern finding. | 10-Q 2026-11-10 |
| Cash and burn | $6.6M cash; operating cash flow $823K a quarter. | Report 2026-09-30 |
| Shares outstanding | 8,602,309 (2026-11-05); 8,576,164 a year earlier; 1,026,078,464 three years earlier. share count fell by more than half since 2023-11-08 with no split on record, which usually means a reverse split; 3y dilution not computed. | Cover page 2026-11-05 |
| Reverse splits, 3 years | 1; latest on 2024-10-18 | Source 2024-10-18 |
| Shelf and offerings, 12 months | 0 S-3/F-3 shelf filings; 0 424B5 takedowns | None on EDGAR |
| Exchange deficiency notices, 12 months | 1 (8-K item 3.01) | 8-K 2026-09-25 |
| Auditor | Baker Tilly US, LLP, Minneapolis, Minnesota, United States; changed auditors 3 times in 24 months | 8-K 4.01 2025-05-21 |
| Late filings, 12 months | None | None on EDGAR |
| Insider trades, 12 months | Bought $38K, sold $7.2M on the open market | SEC Forms 3/4/5 data sets 2026-09-30 |
From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.
Quarterly results
| Quarter | Revenue | Net income | Op. cash flow | Cash | Total debt | TTM revenue | Source |
|---|---|---|---|---|---|---|---|
| Q3 2026 2026-09-30 | $8.6M | -$1.4M | -$851K | $6.6M | $420K | $41.3M | 10-Q 2026-11-10 |
| Q2 2026 2026-06-30 | $9.7M | -$682K | $425K | $9.4M | No debt tags | $44.0M | 10-Q 2026-08-06 |
| Q1 2026 2026-03-31 | $9.6M | -$1.4M | $397K | $10.8M | $20.5M | $44.3M | 10-Q 2026-05-12 |
| Q4 2025 2025-12-31 | $13.4M | $7.7M | $3.3M | $12.0M | $21.9M | $44.1M | 10-K 2026-03-26 |
| Q3 2025 2025-09-30 | $11.3M | $9.7M | $1.1M | $9.6M | $23.3M | $41.0M | 10-Q 2026-11-10 |
| Q2 2025 2025-06-30 | $10.1M | $551K | $993K | $8.5M | No debt tags | $39.1M | 10-Q 2026-08-06 |
| Q1 2025 2025-03-31 | $9.3M | -$6.1M | -$1.5M | $8.5M | No debt tags | $36.2M | 10-Q 2026-05-12 |
| Q4 2024 2024-12-31 | $10.3M | -$13.3M | $741K | $10.2M | No debt tags | $32.6M | 10-K 2026-03-26 |
From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | S-1 | 2024-12-03 |
| Latest annual report | 10-K | 2026-03-26 |
| Latest quarterly / interim | 10-Q | 2026-11-10 |
| Latest current report | 8-K | 2026-11-10 |
| Latest proxy | DEFA14A | 2026-04-29 |
Source: SEC EDGAR submissions feed, 754 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | -16.9% |
| 1 month | -67.6% |
| 3 months | -61.8% |
| Year to date | -93.9% |
| 1 year | -94.6% |
| From 52-week high | -94.8% |
Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Medical/Dental Instruments
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| CTSO | Cytosorbents Corporation | $4.85 | -0.41% | $15.3M |
| RVP | Retractable Technologies Inc. | $0.5600 | +0.02% | $16.8M |
| PAVM | PAVmed Inc. | $1.75 | +7.36% | $14.0M |
| CVRX | CVRx Inc. | $0.6130 | +0.92% | $17.5M |
| PMI | Picard Medical Inc. | $7.24 | +0.14% | $17.8M |
| MODD | Modular Medical Inc. | $1.91 | -3.05% | $18.1M |
| GUTS | Fractyl Health Inc. | $0.9918 | +9.76% | $13.2M |
| DRIO | DarioHealth Corp. | $1.15 | -8.73% | $13.0M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier